Lipocine
(NASDAQ:LPCN)
$0.4566
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$0.4498
-0.0068[-1.49%]
PreMarket: 8:53AM EDT
Day Range- - -52 Wk Range0.36 - 1.89Open / Close- / -Float / Outstanding86.2M / 88.5M
Vol / Avg.- / 195.4KMkt Cap40.4MP/E11.4250d Avg. Price0.44
Div / Yield-Payout Ratio-Total Float86.2MEPS-0.03

Lipocine Stock (NASDAQ:LPCN), Quotes and News Summary

Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range0.36 - 1.89Open / Close- / -Float / Outstanding86.2M / 88.5M
Vol / Avg.- / 195.4KMkt Cap40.4MP/E11.4250d Avg. Price0.44
Div / Yield-Payout Ratio-Total Float86.2MEPS-0.03
Ragothaman Srinivasan - Jul 11, 2022, 10:21AM
Zacks Small Cap Research - May 20, 2022, 11:21AM
Zacks Small Cap Research - May 10, 2022, 3:31PM
PRNewswire - Apr 11, 2022, 8:00AM
InvestorsObserver - Oct 6, 2022, 12:57PM
InvestorsObserver - Apr 25, 2022, 12:11PM
InvestorsObserver - Apr 20, 2022, 1:40PM
InvestorsObserver - Apr 18, 2022, 1:23PM
StockNews - Mar 31, 2022, 6:29AM
InvestorsObserver - Mar 30, 2022, 8:14AM
InvestorsObserver - Mar 28, 2022, 8:55AM
InvestorsObserver - Mar 24, 2022, 2:58PM
InvestorsObserver - Mar 3, 2022, 2:45PM
InvestorsObserver - Jan 5, 2022, 12:07PM
InvestorsObserver - Jan 4, 2022, 6:42AM
Sector: Health Care.Industry: Pharmaceuticals
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.030-0.030 0.0000
REV700.000K0-700.000K
Q2 2022Est.ActualSurprise
EPS-0.040-0.040 0.0000
REV260.000K500.000K240.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lipocine (LPCN) stock?

A

You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lipocine's (LPCN) competitors?

Q

What is the target price for Lipocine (LPCN) stock?

A

The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 666.54% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lipocine (LPCN)?

A

The stock price for Lipocine (NASDAQ: LPCN) is $0.4566 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Lipocine (LPCN) pay a dividend?

A

There are no upcoming dividends for Lipocine.

Q

When is Lipocine (NASDAQ:LPCN) reporting earnings?

A

Lipocine’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q

Is Lipocine (LPCN) going to split?

A

There is no upcoming split for Lipocine.

Q

What sector and industry does Lipocine (LPCN) operate in?

A

Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.